Itasca Capital (NYSE: ICL) and Monsanto (NYSE:MON) are both mid-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.

Valuation & Earnings

This table compares Itasca Capital and Monsanto’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Itasca Capital N/A N/A N/A C($0.10) -40.90
Monsanto $14.64 billion 3.56 $2.26 billion C$5.11 23.15

Monsanto has higher revenue and earnings than Itasca Capital. Itasca Capital is trading at a lower price-to-earnings ratio than Monsanto, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings for Itasca Capital and Monsanto, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itasca Capital 0 2 0 0 2.00
Monsanto 0 8 3 0 2.27

Itasca Capital currently has a consensus target price of C$4.88, indicating a potential upside of 19.19%. Monsanto has a consensus target price of C$123.67, indicating a potential upside of 4.54%. Given Itasca Capital’s higher possible upside, equities research analysts clearly believe Itasca Capital is more favorable than Monsanto.

Risk and Volatility

Itasca Capital has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Monsanto has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500.

Institutional and Insider Ownership

74.4% of Monsanto shares are held by institutional investors. 0.8% of Monsanto shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.


Monsanto pays an annual dividend of C$2.16 per share and has a dividend yield of 1.8%. Itasca Capital does not pay a dividend. Monsanto pays out 42.3% of its earnings in the form of a dividend. Monsanto has raised its dividend for 7 consecutive years.


This table compares Itasca Capital and Monsanto’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Itasca Capital N/A N/A N/A
Monsanto 15.44% 42.40% 11.40%


Monsanto beats Itasca Capital on 11 of the 13 factors compared between the two stocks.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and digital agriculture to assist farmers in decision-making. The Seeds and Genomics segment offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Receive News & Ratings for Itasca Capital Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itasca Capital Ltd and related companies with's FREE daily email newsletter.